Laboratory Corp of America Holdings (LH)

$285.30 +2.63 (0.93%)
Market Cap 23.43B
Revenue (ttm) 13.01B
Net Income (ttm) 746.00M
EPS (ttm) N/A
PE Ratio 17.18
Forward PE 15.94
Profit Margin 5.73%
Debt to Equity Ratio 0.58
Volume 760,600
Avg Vol 746,122
Day's Range N/A - N/A
Shares Out 82.90M
Stochastic %K 79%
Beta 1.03
Analysts Strong Sell
Price Target $306.88

Company Profile

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 336-584-5171
Fax: 336-436-1569
Address:
531 South Spring Street, Burlington, United States
EarningsCentral
EarningsCentral Feb. 20 at 3:45 AM
$LH Q4 2025 Earnings | Record Cash Flow, FDA Cleared Alzheimer’s Test & Future https://youtu.be/NgDtYaGO8nw
0 · Reply
Nosh
Nosh Feb. 20 at 2:45 AM
$LH Nice recovery...does it hold.
0 · Reply
erevnon
erevnon Feb. 18 at 2:31 PM
Baird maintains Labcorp Hldgs $LH at Outperform and raises the price target from $313 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
ZacksResearch
ZacksResearch Feb. 17 at 7:10 PM
$LH beats on earnings… and the stock still drops? 👀 Q4 EPS jumped 18% and topped estimates, but a revenue miss is stealing the spotlight — and shares are sliding in pre-market as investors react cautiously. Is this a buy-the-dip setup or a warning sign? Get the full breakdown 👉 https://www.zacks.com/stock/news/2870557/labcorp-q4-earnings-beat-revenues-miss-stock-down-in-pre-market?cid=sm-stocktwits-2-2870557-teaser-33906&ADID=SYND_STOCKTWITS_TWEET_2_2870557_TEASER_33906
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Feb. 17 at 4:28 PM
$LH
0 · Reply
1986iamwallstreet
1986iamwallstreet Feb. 17 at 2:35 PM
$LH sell the bid in full Play 🩸🩸🩸🩸🩸🩸
0 · Reply
1986iamwallstreet
1986iamwallstreet Feb. 17 at 2:16 PM
$LH Revenue Growth Slowing FY 2025 Revenue Growth: 7.2% 2026 Enterprise Guidance: 4.7% – 6.0% Midpoint growth decelerates to ~5.4%. 🩸🩸🩸🩸🩸🩸
0 · Reply
1986iamwallstreet
1986iamwallstreet Feb. 17 at 2:16 PM
$LH High Debt Load Total Debt: $5.58B Cash: $532M Net Debt ≈ $5.05B In a rising-rate or tighter credit environment, that leverage matters. Interest expense already $224M annually. 🩸🩸🩸🩸🩸🩸🩸🩸🩸
0 · Reply
1986iamwallstreet
1986iamwallstreet Feb. 17 at 2:15 PM
$LH Diagnostics Volume vs Price Mix Requisition volume growth: Organic volume only 1.1% Price/mix 3.0% Volume growth is modest. Pricing is doing more of the work. If reimbursement tightens, that pricing leverage could reverse. 🩸🩸🩸🩸🩸🩸🩸🩸🩸
0 · Reply
1986iamwallstreet
1986iamwallstreet Feb. 17 at 2:07 PM
$LH Risk Factors Mentioned (Noteworthy) Management flagged: Payer regulation risk Reimbursement cuts Inflation IT/cyber risk Litigation exposure Tech disruption Employee retention Spin-off tax risk (Fortrea) Healthcare reimbursement risk remains the biggest macro threat.🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸
0 · Reply
Latest News on LH
Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide

Feb 23, 2026, 7:00 AM EST - 1 day ago

Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide

Labcorp Holdings Inc. (LH) Q4 2025 Earnings Call Transcript

Feb 17, 2026, 4:15 PM EST - 6 days ago

Labcorp Holdings Inc. (LH) Q4 2025 Earnings Call Transcript

Labcorp forecasts upbeat annual profit on strong demand for diagnostic products

Feb 17, 2026, 7:59 AM EST - 7 days ago

Labcorp forecasts upbeat annual profit on strong demand for diagnostic products

Labcorp Announces 2025 Fourth Quarter and Full Year Results

Feb 17, 2026, 6:50 AM EST - 7 days ago

Labcorp Announces 2025 Fourth Quarter and Full Year Results

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care

Feb 11, 2026, 7:00 AM EST - 13 days ago

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care

Labcorp Appoints John H. Sampson, M.D.

Feb 9, 2026, 8:30 AM EST - 15 days ago

Labcorp Appoints John H. Sampson, M.D.

Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026

Jan 15, 2026, 4:15 PM EST - 5 weeks ago

Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026

Labcorp Declares Quarterly Dividend

Jan 14, 2026, 6:50 AM EST - 5 weeks ago

Labcorp Declares Quarterly Dividend

Labcorp Holdings Inc. (LH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 10:15 PM EST - 5 weeks ago

Labcorp Holdings Inc. (LH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk

Jan 13, 2026, 7:00 AM EST - 6 weeks ago

Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk

Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs

Jan 8, 2026, 9:00 AM EST - 6 weeks ago

Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs

NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp

Jan 8, 2026, 8:30 AM EST - 6 weeks ago

NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp

Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference

Dec 30, 2025, 4:15 PM EST - 7 weeks ago

Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference

Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks

Dec 15, 2025, 10:00 AM EST - 2 months ago

Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks

Community Health Systems Completes Sale of Select Outreach Laboratory Assets to Labcorp

Dec 2, 2025, 4:15 PM EST - 2 months ago

Community Health Systems Completes Sale of Select Outreach Laboratory Assets to Labcorp

CYH

Labcorp Appoints Victor Bulto to Board of Directors

Nov 24, 2025, 8:30 AM EST - 3 months ago

Labcorp Appoints Victor Bulto to Board of Directors

Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research

Nov 19, 2025, 7:04 AM EST - 3 months ago

Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research

Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research

Nov 17, 2025, 9:00 AM EST - 3 months ago

Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research

Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support

Oct 28, 2025, 2:45 PM EDT - 4 months ago

Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support

Labcorp Holdings Inc. (LH) Q3 2025 Earnings Call Transcript

Oct 28, 2025, 12:31 PM EDT - 4 months ago

Labcorp Holdings Inc. (LH) Q3 2025 Earnings Call Transcript

Labcorp lifts annual profit forecast on strong diagnostic test demand

Oct 28, 2025, 6:52 AM EDT - 4 months ago

Labcorp lifts annual profit forecast on strong diagnostic test demand

Labcorp Announces 2025 Third Quarter Results

Oct 28, 2025, 6:50 AM EDT - 4 months ago

Labcorp Announces 2025 Third Quarter Results

Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings

Oct 23, 2025, 7:00 AM EDT - 4 months ago

Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings

Praia Health, Providence, and Labcorp Collaborate to Transform Patient Engagement and Lab Order Adherence

Oct 20, 2025, 9:00 AM EDT - 4 months ago

Praia Health, Providence, and Labcorp Collaborate to Transform Patient Engagement and Lab Order Adherence

Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities

Sep 30, 2025, 7:00 AM EDT - 5 months ago

Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities

Labcorp to Announce Third Quarter Financial Results on October 28, 2025

Sep 25, 2025, 4:15 PM EDT - 5 months ago

Labcorp to Announce Third Quarter Financial Results on October 28, 2025

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Sep 15, 2025, 8:30 AM EDT - 5 months ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

OPK

Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 10:26 AM EDT - 5 months ago

Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 27, 2025, 4:15 PM EDT - 6 months ago

Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease

Aug 18, 2025, 7:00 AM EDT - 6 months ago

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease

Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search

Jul 30, 2025, 7:12 AM EDT - 7 months ago

Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search

Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU

Jul 29, 2025, 7:00 AM EDT - 7 months ago

Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU

These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings

Jul 25, 2025, 9:45 AM EDT - 7 months ago

These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings

Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 2:38 PM EDT - 7 months ago

Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript

Why Is Testing Giant Labcorp Stock Surging On Thursday?

Jul 24, 2025, 12:27 PM EDT - 7 months ago

Why Is Testing Giant Labcorp Stock Surging On Thursday?

Labcorp raises annual profit forecast on strong diagnostic testing demand

Jul 24, 2025, 7:00 AM EDT - 7 months ago

Labcorp raises annual profit forecast on strong diagnostic testing demand

Labcorp Announces 2025 Second Quarter Results

Jul 24, 2025, 6:50 AM EDT - 7 months ago

Labcorp Announces 2025 Second Quarter Results

Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp

Jul 22, 2025, 4:15 PM EDT - 7 months ago

Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp

CYH

Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low

Jun 30, 2025, 6:58 AM EDT - 8 months ago

Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low

Labcorp to Announce Second Quarter Financial Results on July 24, 2025

Jun 26, 2025, 4:10 PM EDT - 8 months ago

Labcorp to Announce Second Quarter Financial Results on July 24, 2025

ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage

Jun 2, 2025, 7:00 AM EDT - 9 months ago

ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage

Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research

May 30, 2025, 7:00 AM EDT - 9 months ago

Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research

Labcorp to Webcast Its Annual Meeting of Shareholders May 15

May 8, 2025, 4:15 PM EDT - 10 months ago

Labcorp to Webcast Its Annual Meeting of Shareholders May 15

Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 4:21 PM EDT - 10 months ago

Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript

Labcorp beats quarterly profit estimate on diagnostic test demand

Apr 29, 2025, 6:56 AM EDT - 10 months ago

Labcorp beats quarterly profit estimate on diagnostic test demand

Labcorp Announces 2025 First Quarter Results

Apr 29, 2025, 6:50 AM EDT - 10 months ago

Labcorp Announces 2025 First Quarter Results

Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions

Apr 23, 2025, 7:00 AM EDT - 10 months ago

Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions

Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics

Apr 11, 2025, 5:32 AM EDT - 11 months ago

Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics

Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease

Apr 2, 2025, 7:00 AM EDT - 11 months ago

Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease

Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide

Apr 1, 2025, 8:32 AM EDT - 11 months ago

Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide

EarningsCentral
EarningsCentral Feb. 20 at 3:45 AM
$LH Q4 2025 Earnings | Record Cash Flow, FDA Cleared Alzheimer’s Test & Future https://youtu.be/NgDtYaGO8nw
0 · Reply
Nosh
Nosh Feb. 20 at 2:45 AM
$LH Nice recovery...does it hold.
0 · Reply
erevnon
erevnon Feb. 18 at 2:31 PM
Baird maintains Labcorp Hldgs $LH at Outperform and raises the price target from $313 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
ZacksResearch
ZacksResearch Feb. 17 at 7:10 PM
$LH beats on earnings… and the stock still drops? 👀 Q4 EPS jumped 18% and topped estimates, but a revenue miss is stealing the spotlight — and shares are sliding in pre-market as investors react cautiously. Is this a buy-the-dip setup or a warning sign? Get the full breakdown 👉 https://www.zacks.com/stock/news/2870557/labcorp-q4-earnings-beat-revenues-miss-stock-down-in-pre-market?cid=sm-stocktwits-2-2870557-teaser-33906&ADID=SYND_STOCKTWITS_TWEET_2_2870557_TEASER_33906
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Feb. 17 at 4:28 PM
$LH
0 · Reply
1986iamwallstreet
1986iamwallstreet Feb. 17 at 2:35 PM
$LH sell the bid in full Play 🩸🩸🩸🩸🩸🩸
0 · Reply
1986iamwallstreet
1986iamwallstreet Feb. 17 at 2:16 PM
$LH Revenue Growth Slowing FY 2025 Revenue Growth: 7.2% 2026 Enterprise Guidance: 4.7% – 6.0% Midpoint growth decelerates to ~5.4%. 🩸🩸🩸🩸🩸🩸
0 · Reply
1986iamwallstreet
1986iamwallstreet Feb. 17 at 2:16 PM
$LH High Debt Load Total Debt: $5.58B Cash: $532M Net Debt ≈ $5.05B In a rising-rate or tighter credit environment, that leverage matters. Interest expense already $224M annually. 🩸🩸🩸🩸🩸🩸🩸🩸🩸
0 · Reply
1986iamwallstreet
1986iamwallstreet Feb. 17 at 2:15 PM
$LH Diagnostics Volume vs Price Mix Requisition volume growth: Organic volume only 1.1% Price/mix 3.0% Volume growth is modest. Pricing is doing more of the work. If reimbursement tightens, that pricing leverage could reverse. 🩸🩸🩸🩸🩸🩸🩸🩸🩸
0 · Reply
1986iamwallstreet
1986iamwallstreet Feb. 17 at 2:07 PM
$LH Risk Factors Mentioned (Noteworthy) Management flagged: Payer regulation risk Reimbursement cuts Inflation IT/cyber risk Litigation exposure Tech disruption Employee retention Spin-off tax risk (Fortrea) Healthcare reimbursement risk remains the biggest macro threat.🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸
0 · Reply
OpenOutcrier
OpenOutcrier Feb. 17 at 1:55 PM
$LH (+0.8% pre) Labcorp forecasts upbeat annual profit on strong demand for diagnostic products https://ooc.bz/l/93525
0 · Reply
DonCorleone77
DonCorleone77 Feb. 17 at 12:27 PM
$LH Labcorp reports Q4 adjusted EPS $4.07, consensus $3.94 Reports Q4 revenue $3.52B, consensus $3.56B. "In 2025, Labcorp grew revenue over 7% and delivered double-digit adjusted EPS growth, margin expansion and strong free cash flow. Performance was driven by continued strength in our Diagnostics and Central Laboratory businesses," said Adam Schechter, Chairman and CEO of Labcorp. "We made significant progress across our strategic priorities, and we begin 2026 with strong momentum, and expect continued strong performance in 2026 as we remain focused on growth."
0 · Reply
1986iamwallstreet
1986iamwallstreet Feb. 17 at 12:05 PM
$LH rev miss 🩸🩸🩸🩸
0 · Reply
dontfeedthebashers
dontfeedthebashers Feb. 17 at 12:04 PM
$LH okay, but where's my raise 😭
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 17 at 12:02 PM
$LH Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $2.00 up 16.28% YoY • Reported revenue of $3.52B up 5.60% YoY • Labcorp expects Full-Year 2026 Enterprise Revenue of $14.61B to $14.79B, a midpoint growth of 5.4%. Adjusted EPS is guided to $17.55 to $18.25, with Free Cash Flow of $1.24B to $1.36B.
0 · Reply
DonCorleone77
DonCorleone77 Feb. 14 at 3:06 PM
$LH $LDOS $MDT Some notable companies reporting before Tuesday's open, with earnings consensus estimates: - LabCorp (LH), consensus $3.94 - Leidos (LDOS), consensus $2.61 - Medtronic (MDT), consensus $1.33
0 · Reply
tikiyan
tikiyan Feb. 13 at 6:01 PM
$LH when $330?
0 · Reply
1986iamwallstreet
1986iamwallstreet Feb. 13 at 5:58 PM
$LH 🩸🩸🩸🩸🩸🩸🩸
0 · Reply
_TP888
_TP888 Feb. 12 at 3:58 PM
$LH | $280.00 | Put | Premium: $135,000
0 · Reply
onen1r3
onen1r3 Feb. 12 at 12:33 AM
$LH StockTwits missed it April Delaney of MD House Representatives purchased. Just need to start following these politicians…they seem to know before the rest of the world knows.
0 · Reply
Small_time_trader
Small_time_trader Feb. 10 at 3:48 PM
$LH $DGX >> $LH
0 · Reply
ZacksResearch
ZacksResearch Feb. 10 at 2:22 PM
$LH Q4 earnings preview: Can Labcorp maintain its winning streak? 🧐 The Zacks Consensus Estimate points to a 15% improvement in EPS to $3.95, with revenues expected to jump 6.6% to $3.55B. The Diagnostics segment is likely to shine with a 7% revenue boost, driven by strategic acquisitions and robust demand in specialty areas. Full details on Labcorp's setup here 👉 https://www.zacks.com/stock/news/2846652/labcorps-q4-earnings-preview-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2846652-body-32747&ADID=SYND_STOCKTWITS_TWEET_2_2846652_BODY_32747
0 · Reply